-
Most Recent
Search Results
240 results for abv
AbbVie Inc (ABBV) Stock STILL Has Much More Room to Run Higher
ABBV stock has a lot more long-term oomph when you consider its current pipeline. Here’s why investors shouldn’t overlook AbbVie.
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q2 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions
With AbbVie’s buyout of Allergan officially finalized, ABBV stock has moved significantly higher since then. However, ABBV is so much more than this headline event.
AbbVie Inc Stock Up on Strong Earnings, Guidance Update
AbbVie (ABBV) stock was up on Thursday following the release of a positive earnings report for the first quarter of the year.
Why Vale SA (VALE), Lululemon Athletica Inc. (LULU) and AbbVie Inc. (ABBV) Are 3 of Today’s Worst Stocks
AbbVie (ABBV), Lululemon Athletica (LULU) and Vale SA (VALE) led the marketwide bearish charge on Monday.
Anthropic’s Claude Mythos Leak Is Bigger Than You Think
Anthropic’s Claude Mythos leak reveals a major AI breakthrough – boosting infrastructure stocks while putting SaaS business models at risk.
Anthropic’s 10,000% Revenue Growth Rate Could Make This the IPO of 2026
Anthropic’s revenue just exploded from $1 billion to $30 billion in 15 months. Here’s what it means for AI investors and why the Anthropic IPO…
Gala Makes for an Intriguing Bet, But Gamble Responsibly
While cryptocurrencies represent a tough animal to figure out, gaming-centric Gala might be able to climb above the noise.
Why Is AbbVie Stock Down Today?
AbbVie (ABBV) stock is slipping on Friday following the release of the biopharmaceutical company’s earnings report for Q1 2022.
AbbVie Inc Stock Soars on Strong Q4 Earnings Beat
AbbVie (ABBV) stock was flying high today following the release of a positive earnings report for the fourth quarter of 2017.
Why You Should Buy ABBV Stock for Income and Value
Although there could be further weakness in the AbbVie stock price in the coming months, ABBV stock belongs in a diversified portfolio.
Shinzo Abe’s Kamikaze Politics
The new prime minister promises to reflate the economy to end Japan’s stagnation. Too bad that will only add to Tokyo’s crushing debt burden.
EOLS Stock: The Big News That Has Evolus Shares Skyrocketing Today
Evolus (EOLS) stock was on the rise Friday following news that it’s no longer dealing with lawsuits from AbbVie (ABBV) and Medytox.
AbbVie Stock Has a $10 Upside Opportunity — Buy It Now
There is a $10 technical opportunity in ABBV stock just around the corner. Get on board AbbVie while the value is still reasonable.
Why Best Buy Co Inc (BBY), AbbVie Inc (ABBV), Smith & Wesson Holding Corp (SWHC) are Three of Today’s Worst Stocks
Smith & Wesson (SWHC), Best Buy (BBY) and AbbVie (ABBV) got the new trading week started on the wrong foot.
Software Stocks Are Cracking. Is Your Portfolio Exposed?
Software used to be the market’s golden child. At one point, those companies looked untouchable. Then the world changed.
Exceptional Metrics for Sales Growth Keep AbbVie (ABBV) a Strong Buy at recent price of $116.34
AbbVie Inc’s Strong Buy recommendation is the outcome of an analytical process that is proprietary and produced results that were above average in 5 areas:…
Monday’s Vital Data: Apple Inc. (AAPL), Netflix Inc. (NFLX) and AbbVie Inc. (ABBV)
A look at what has sparked some major options activity in Apple Inc. (AAPL), Netflix Inc. (NFLX) and AbbVie Inc (ABBV).
Monday’s Vital Data: Bank of America Corp (BAC), Netflix, Inc. (NFLX) and AbbVie Inc (ABBV)
Bank of America (BAC) options traders prep for earnings, Netflix (NFLX) draws a bullish brokerage note, AbbVie’s (ABBV) Imbruvica was approved in the EU.
Why the Energy Bull Case Is Still Intact
The prognosis for global oil and gas markets remains deeply unsettled, and investors who panic out of their energy positions may find themselves on the…
Consistent Clinical Results Indicate Upside for AbbVie Stock
ABBV stock can move higher as it trades at a very reasonable valuation. Meanwhile, AbbVie’s financials and dividend payments sweeten the deal.
$192 Price Target Makes AbbVie Stock a Notable Healthcare Pick
ABBV stock could have substantial room to run as a big-bank analyst assigns a high rating to relentlessly innovative AbbVie.
9 – 10 of 240 results
